Cure Hepatitis C Act of 2026
The Cure Hepatitis C Act of 2026 establishes a federal program to eliminate hepatitis C by creating a subscription model that allows the government to purchase antiviral drugs directly from manufacturers and distribute them at no cost to specific patient groups. These groups include individuals in Medicaid or CHIP programs, those without health insurance, patients in correctional facilities, and those receiving care through the Indian Health Service. The bill also expands Medicare coverage by removing deductibles and copayments for hepatitis C treatments between 2028 and 2032. To support these efforts, the legislation authorizes funding for state grants to improve screening and treatment access, mandates the creation of a national strategy and performance dashboard, and requires coordination with various federal agencies and stakeholders.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2026
Committee Review
Floor Vote
President
Introduced Jul 14, 2026
Last action Jul 14, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jul 14, 2026
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jul 14, 2026
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 9682
Scope: US
Hi! I can help you understand HR 9682. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline